Editorial: Cancer therapy: The challenge of handling a double-edged sword

• Kulmira Nurgali,
• Kulmira Nurgali,
• Kulmira Nurgali,
• John A. Rudd,
• John A. Rudd,
• Halina Was,
• Raquel Abalo,
• Raquel Abalo,
• Raquel Abalo,
• Raquel Abalo,
• Raquel Abalo

Affiliations

Kulmira Nurgali

Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia

Kulmira Nurgali

Department of Medicine Western Health, University of Melbourne, Melbourne, VIC, Australia

Kulmira Nurgali

Regenerative Medicine and Stem Cells Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia

John A. Rudd

School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

John A. Rudd

The Laboratory Animal Services Centre, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Halina Was

Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, Warsaw, Poland

Raquel Abalo

Área de Farmacología y Nutrición, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos (URJC), Alcorcón, Spain

Raquel Abalo

Unidad Asociada I+D+i del Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain

Raquel Abalo

High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut-URJC), URJC, Alcorcón, Spain

Raquel Abalo

0Grupo de Trabajo de Ciencias Básicas en Dolor y Analgesia de la Sociedad Española del Dolor, Madrid, Spain

Raquel Abalo

1Grupo de Trabajo de Cannabinoides de la Sociedad Española del Dolor, Madrid, Spain